Diabetes Type I
12
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
8.3%
1 terminated out of 12 trials
87.5%
+1.0% vs benchmark
33%
4 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (12)
A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes
Sitagliptin in Type I Diabetic Patients
Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment
Diabetes Virus Detection Project, Intervention With GAD-alum
Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm
Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes
A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial
Childhood Diabetes
12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.
Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives
Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy